Semaglutide is a GLP-1 agonist that works by reducing appetite, delaying gastric emptying, increasing insulin release, and lowering the amount of glucagon released. Semaglutide is a glucagon-like ...
In this video interview, Dominique Demolle, CEO of Cognivia, highlights how patient non-adherence could increase trial ...
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...
Nishit Agarwal exemplifies excellence in Biomedical AI and Signal Processing with extensive experience in developing ...
The ClinicalTrials.Gov Support Team expanded outreach efforts to study teams and launched a series of how-to videos to answer frequently asked questions. Northwestern Medicine’s Clinical Research Unit ...
Oncology studies present unique challenges when it comes to participant treatment, resupply, and study management.
Total duration of antibiotic therapy in adults hospitalized with sepsis was significantly shorter among those who received PCT-guided care vs standard care.
PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...